Stay updated on AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial
Sign up to get notified when there's something new on the AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial page.

Latest updates to the AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial page
- Check4 days agoChange DetectedThe updates appear to modify only the Study Record Dates timestamps (e.g., Results First Posted, Results First Submitted, Last Update Posted); core study details, eligibility criteria, and outcome measures do not change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded concrete extension-study results, dosing regimens, participant eligibility, safety and efficacy endpoints, and results-reporting dates; removed some older, high-level extension details.SummaryDifference53%

- Check33 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.SummaryDifference0.0%

- Check48 days agoChange Detected- Updated the page revision from v3.0.1 to v3.0.2. - Removed the 'Back to Top' link.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now shows a 'Results Submitted' confirmation instead of 'No Results Posted' and updates the revision from v3.0.0 to v3.0.1; a 'Back to Top' link was also added.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as specific drug information related to quinidine sulfate. Notably, several locations in Bulgaria, Czechia, France, Spain, and Poland have been included, while previous location details and related medical information have been removed.SummaryDifference4%

Stay in the know with updates to AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial page.